drugset / Trial / NCT02058849

Randomized Study of Beet Root in Locally Advanced Squamous Cell Cancer of the Head and Neck

NCT02058849 ↗

Phase 2 Completed 13 enrolled David Travis Thomas
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of the current proposal is to determine if concentrated beet root could improve medical treatment compliance as defined by completion of radiotherapy and 3 cycles of chemoradiation without dose reduction, preserve fat-free mass, and strength while reducing mucositis. The investigators central hypothesis is that dietary nitrate supplementation in head and neck cancer patients receiving aggressive medical care will improve compliance with medical treatment by attenuating the loss of muscle mass and strength and reducing symptoms (mucositis) associated with treatment compared to patients receiving standard care with placebo.

Timeline

Start
2014-12
Primary completion
2018-04-01
Completion
2018-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Beetroot Unknown 10 g —

Indications